{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:34:27Z","timestamp":1790706867203,"version":"4.1.0"},"reference-count":214,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chengguan District Science and Technology Bureau project","award":["2022SHFZ0020"],"award-info":[{"award-number":["2022SHFZ0020"]}]},{"name":"Chengguan District Science and Technology Bureau project","award":["2022SHFZQ022"],"award-info":[{"award-number":["2022SHFZQ022"]}]},{"name":"Gansu Province Science and Technology Plan Project","award":["24YFWA004"],"award-info":[{"award-number":["24YFWA004"]}]},{"name":"Gansu Province Science and Technology Plan Project","award":["24JRRA031"],"award-info":[{"award-number":["24JRRA031"]}]},{"name":"the\u00a0National Key R&D Program of China","award":["2018YFE0205102"],"award-info":[{"award-number":["2018YFE0205102"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"DOI":"10.1186\/s11658-026-00895-y","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T16:13:28Z","timestamp":1774023208000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting dormant cancer cells: ferroptosis as a precision therapeutic strategy"],"prefix":"10.1186","volume":"31","author":[{"given":"Sijia","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaozhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuixia","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"issue":"3","key":"895_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"895_CR2","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.3390\/cancers6042343","volume":"6","author":"M Retsky","year":"2014","unstructured":"Retsky M, Demicheli R. Multimodal hazard rate for relapse in breast cancer: quality of data and calibration of computer simulation. Cancers. 2014;6(4):2343\u201355.","journal-title":"Cancers"},{"issue":"2","key":"895_CR3","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0022-5347(05)66046-6","volume":"166","author":"D Weckermann","year":"2001","unstructured":"Weckermann D, M\u00fcller P, Wawroschek F, Harzmann R, Riethm\u00fcller G, Schlimok G. Disseminated cytokeratin positive tumor cells in the bone marrow of patients with prostate cancer: detection and prognostic value. J Urol. 2001;166(2):699\u2013704.","journal-title":"J Urol"},{"issue":"5","key":"895_CR4","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"issue":"39","key":"895_CR5","doi-asserted-by":"publisher","first-page":"E771","DOI":"10.1073\/pnas.1106149108","volume":"108","author":"AJ Wolpaw","year":"2011","unstructured":"Wolpaw AJ, Shimada K, Skouta R, Welsch ME, Akavia UD, Pe\u2019er D, et al. Modulatory profiling identifies mechanisms of small molecule-induced cell death. Proc Natl Acad Sci USA. 2011;108(39):E771\u201380.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"895_CR6","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JPF Angeli","year":"2014","unstructured":"Angeli JPF, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 2014;16(12):1180\u201391.","journal-title":"Nat Cell Biol"},{"key":"895_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.semcdb.2014.07.013","volume":"35","author":"W Zhou","year":"2014","unstructured":"Zhou W, Yuan J. Necroptosis in health and diseases. Semin Cell Dev Biol. 2014;35:14\u201323.","journal-title":"Semin Cell Dev Biol"},{"issue":"7679","key":"895_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer MJ, Viswanathan VS, Ryan MJ, Bole D, Eaton JK, Matov A, et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature. 2017;551(7679):247\u201350.","journal-title":"Nature"},{"key":"895_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103480","author":"B Puente-Cobacho","year":"2025","unstructured":"Puente-Cobacho B, Esteo C, Altea-Manzano P, Garcia-Perez JL, Quiles JL, Sanchez-Rovira P, et al. De novo lipogenesis protects dormant breast cancer cells from ferroptosis and promotes metastasis. Redox Biol. 2025. https:\/\/doi.org\/10.1016\/j.redox.2024.103480.","journal-title":"Redox Biol"},{"key":"895_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104496","author":"X Liu","year":"2023","unstructured":"Liu X, Peng S, Tang G, Xu G, Xie Y, Shen D, et al. Fasting-mimicking diet synergizes with ferroptosis against quiescent, chemotherapy-resistant cells. EBioMedicine. 2023. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104496.","journal-title":"EBioMedicine"},{"issue":"9","key":"895_CR11","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1517\/14712598.2010.512003","volume":"10","author":"LC Amler","year":"2010","unstructured":"Amler LC. HER3 mRNA as a predictive biomarker in anticancer therapy. Expert Opin Biol Ther. 2010;10(9):1343\u201355.","journal-title":"Expert Opin Biol Ther"},{"issue":"2","key":"895_CR12","doi-asserted-by":"publisher","first-page":"E93","DOI":"10.1016\/S1470-2045(14)70412-7","volume":"16","author":"T Kamada","year":"2015","unstructured":"Kamada T, Tsujii H, Blakely EA, Debus J, De Neve W, Durante M, et al. Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience. Lancet Oncol. 2015;16(2):E93\u2013100.","journal-title":"Lancet Oncol"},{"issue":"23","key":"895_CR13","doi-asserted-by":"publisher","first-page":"5014","DOI":"10.1158\/0008-5472.CAN-15-1370","volume":"75","author":"AC Yeh","year":"2015","unstructured":"Yeh AC, Ramaswamy S. Mechanisms of cancer cell dormancy-another hallmark of cancer? Cancer Res. 2015;75(23):5014\u201322.","journal-title":"Cancer Res"},{"issue":"1","key":"895_CR14","first-page":"197","volume":"42","author":"F Francescangeli","year":"2023","unstructured":"Francescangeli F, De Angelis ML, Rossi R, Cuccu A, Giuliani A, De Maria R, et al. Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution. Cancer Metastasis Rev. 2023;42(1):197\u2013215.","journal-title":"Cancer Metastasis Rev"},{"issue":"5","key":"895_CR15","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.molonc.2010.06.001","volume":"4","author":"MA Essers","year":"2010","unstructured":"Essers MA, Trumpp A. Targeting leukemic stem cells by breaking their dormancy. Mol Oncol. 2010;4(5):443\u201350.","journal-title":"Mol Oncol"},{"issue":"18","key":"895_CR16","doi-asserted-by":"publisher","first-page":"5850","DOI":"10.1158\/1078-0432.CCR-10-2574","volume":"17","author":"MS Sosa","year":"2011","unstructured":"Sosa MS, Avivar-Valderas A, Bragado P, Wen H-C, Aguirre-Ghiso JA. ERK1\/2 and p38\u03b1\/\u03b2 signaling in tumor cell quiescence: opportunities to control dormant residual disease. Clin Cancer Res. 2011;17(18):5850\u20137.","journal-title":"Clin Cancer Res"},{"key":"895_CR17","volume-title":"The spread of tumours in the human body","author":"RA Willis","year":"1934","unstructured":"Willis RA. The spread of tumours in the human body. London: Nature; 1934."},{"key":"895_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.4888.607","author":"G Hadfield","year":"1954","unstructured":"Hadfield G. The dormant cancer cell. BMJ. 1954. https:\/\/doi.org\/10.1136\/bmj.2.4888.607.","journal-title":"BMJ"},{"issue":"6795","key":"895_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1136\/bmj.303.6795.155","volume":"303","author":"H Joensuu","year":"1991","unstructured":"Joensuu H, Toikkanen S. Comparison of breast carcinomas diagnosed in the 1980s with those diagnosed in the 1940s to 1960s. BMJ. 1991;303(6795):155\u20138.","journal-title":"BMJ"},{"issue":"5","key":"895_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000279","volume":"7","author":"FM Blows","year":"2010","unstructured":"Blows FM, Driver KE, Schmidt MK, Broeks A, van Leeuwen FE, Wesseling J, et al. Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med. 2010;7(5):e1000279.","journal-title":"PLoS Med"},{"issue":"3380","key":"895_CR21","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1126\/science.130.3380.918","volume":"130","author":"B Fisher","year":"1959","unstructured":"Fisher B, Fisher ER. Experimental evidence in support of the dormant tumor cell. Science. 1959;130(3380):918\u20139.","journal-title":"Science"},{"issue":"4","key":"895_CR22","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1084\/jem.138.4.745","volume":"138","author":"J Folkman","year":"1973","unstructured":"Folkman J, Hochberg M. Self-regulation of growth in three dimensions. J Exp Med. 1973;138(4):745\u201353.","journal-title":"J Exp Med"},{"issue":"10","key":"895_CR23","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/nm1095-1035","volume":"1","author":"MM Heiss","year":"1995","unstructured":"Heiss MM, Allgayer H, Gruetzner KU, Funke I, Babic R, Jauch KW, et al. Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancer. Nat Med. 1995;1(10):1035\u20139.","journal-title":"Nat Med"},{"key":"895_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/biom11020130","author":"J Badia-Ramentol","year":"2021","unstructured":"Badia-Ramentol J, Linares J, G\u00f3mez-Llonin A, Calon A. Minimal residual disease, metastasis and immunity. Biomolecules. 2021. https:\/\/doi.org\/10.3390\/biom11020130.","journal-title":"Biomolecules"},{"issue":"7","key":"895_CR25","first-page":"1684","volume":"63","author":"JA Aguirre-Ghiso","year":"2003","unstructured":"Aguirre-Ghiso JA, Estrada Y, Liu D, Ossowski L. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). Cancer Res. 2003;63(7):1684\u201395.","journal-title":"Cancer Res"},{"issue":"11","key":"895_CR26","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nrc2256","volume":"7","author":"JA Aguirre-Ghiso","year":"2007","unstructured":"Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer. 2007;7(11):834\u201346.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"895_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41568-023-00642-x","volume":"24","author":"J Agudo","year":"2024","unstructured":"Agudo J, Aguirre-Ghiso JA, Bhatia M, Chodosh LA, Correia AL, Klein CA. Targeting cancer cell dormancy. Nat Rev Cancer. 2024;24(2):97\u2013104.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"895_CR28","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41568-020-0263-0","volume":"20","author":"TG Phan","year":"2020","unstructured":"Phan TG, Croucher PI. The dormant cancer cell life cycle. Nat Rev Cancer. 2020;20(7):398\u2013411.","journal-title":"Nat Rev Cancer"},{"issue":"7924","key":"895_CR29","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/s41586-022-05043-y","volume":"608","author":"Y Ohta","year":"2022","unstructured":"Ohta Y, Fujii M, Takahashi S, Takano A, Nanki K, Matano M, et al. Cell-matrix interface regulates dormancy in human colon cancer stem cells. Nature. 2022;608(7924):784\u201394.","journal-title":"Nature"},{"issue":"1","key":"895_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02250-9","volume":"24","author":"S Yang","year":"2025","unstructured":"Yang S, Seo J, Choi J, Kim SH, Kuk Y, Park KC, et al. Towards understanding cancer dormancy over strategic hitching up mechanisms to technologies. Mol Cancer. 2025;24(1):47.","journal-title":"Mol Cancer"},{"issue":"7864","key":"895_CR31","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-021-03614-z","volume":"594","author":"AL Correia","year":"2021","unstructured":"Correia AL, Guimaraes JC, Auf der Maur P, De Silva D, Trefny MP, Okamoto R, et al. Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy. Nature. 2021;594(7864):566\u201371.","journal-title":"Nature"},{"issue":"9","key":"895_CR32","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.ccell.2025.06.007","volume":"43","author":"D He","year":"2025","unstructured":"He D, Wu Q, Tian P, Liu Y, Jia Z, Li Z, et al. Chemotherapy awakens dormant cancer cells in lung by inducing neutrophil extracellular traps. Cancer Cell. 2025;43(9):1622\u201336.","journal-title":"Cancer Cell"},{"key":"895_CR33","first-page":"55","volume-title":"Systems biology of tumor dormancy, advances in experimental medicine and biology","author":"H Enderling","year":"2012","unstructured":"Enderling H. Cancer stem cells and tumor dormancy. In: Enderling H, Almog N, Hlatky L, editors. Systems biology of tumor dormancy, advances in experimental medicine and biology, vol. 7342012. New York: Springer; 2012. p. 55\u201371."},{"issue":"8","key":"895_CR34","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/jcp.31052","volume":"238","author":"JH Zhang","year":"2023","unstructured":"Zhang JH, Xie Y, Liu XY, Gan L, Li PP, Dou ZH, et al. Carbon ions trigger DNA damage response to overcome radioresistance by regulating \u03b2-catenin signaling in quiescent HeLa cells. J Cell Physiol. 2023;238(8):1836\u201349.","journal-title":"J Cell Physiol"},{"issue":"3","key":"895_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-025-02607-6","volume":"42","author":"S Ferdousmakan","year":"2025","unstructured":"Ferdousmakan S, Mansourian D, Seyedi Asl FS, Fathi Z, Maleki-Sheikhabadi F, Afjadi MN, et al. Autophagy induced by metabolic processes leads to solid tumor cell metastatic dormancy and recurrence. Med Oncol. 2025;42(3):62.","journal-title":"Med Oncol"},{"issue":"1","key":"895_CR36","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12967-024-05084-z","volume":"22","author":"B Deng","year":"2024","unstructured":"Deng B, Kong W, Shen X, Han C, Zhao Z, Chen S, et al. The role of DGAT1 and DGAT2 in regulating tumor cell growth and their potential clinical implications. J Transl Med. 2024;22(1):290.","journal-title":"J Transl Med"},{"issue":"1","key":"895_CR37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41467-023-44412-7","volume":"15","author":"H Lee","year":"2024","unstructured":"Lee H, Horbath A, Kondiparthi L, Meena JK, Lei G, Dasgupta S, et al. Cell cycle arrest induces lipid droplet formation and confers ferroptosis resistance. Nat Commun. 2024;15(1):79.","journal-title":"Nat Commun"},{"issue":"2","key":"895_CR38","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/hep.28574","volume":"64","author":"X Sun","year":"2016","unstructured":"Sun X, Niu X, Chen R, He W, Chen D, Kang R, et al. Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis. Hepatology. 2016;64(2):488\u2013500.","journal-title":"Hepatology"},{"key":"895_CR39","doi-asserted-by":"crossref","unstructured":"Alvarez SW, Sviderskiy VO, Terzi EM, Papagiannakopoulos T, Moreira AL, Adams S, et al. NFS1 undergoes positive selection in lung tumors and protects cells from ferroptosis. Cancer Res. 2018;78(13)","DOI":"10.1158\/1538-7445.AM2018-NG02"},{"issue":"8","key":"895_CR40","doi-asserted-by":"publisher","first-page":"e139434","DOI":"10.1172\/JCI139434","volume":"131","author":"Z Jiang","year":"2021","unstructured":"Jiang Z, Lim S-O, Yan M, Hsu JL, Yao J, Wei Y, et al. TYRO3 induces anti-PD-1\/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis. J Clinic Investig. 2021;131(8):e139434.","journal-title":"J Clinic Investig."},{"issue":"1","key":"895_CR41","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.canlet.2016.07.035","volume":"381","author":"J-L Roh","year":"2016","unstructured":"Roh J-L, Kim EH, Jang HJ, Park JY, Shin D. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer. Cancer Lett. 2016;381(1):96\u2013103.","journal-title":"Cancer Lett"},{"key":"895_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14324-x","author":"Y Yang","year":"2020","unstructured":"Yang Y, Luo M, Zhang K, Zhang J, Gao T, O\u2019 Connell D, et al. Nedd4 ubiquitylates VDAC2\/3 to suppress erastin-induced ferroptosis in melanoma. Nat Commun. 2020. https:\/\/doi.org\/10.1038\/s41467-020-14324-x.","journal-title":"Nat Commun"},{"issue":"5","key":"895_CR43","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ccell.2018.03.017","volume":"33","author":"J Tsoi","year":"2018","unstructured":"Tsoi J, Robert L, Paraiso K, Galvan C, Sheu KM, Lay J, et al. Multi-stage differentiation defines melanoma subtypes with differential vulnerability to drug-induced iron-dependent oxidative stress. Cancer Cell. 2018;33(5):890-904.e5.","journal-title":"Cancer Cell"},{"key":"895_CR44","doi-asserted-by":"publisher","first-page":"913669","DOI":"10.3389\/fonc.2022.913669","volume":"12","author":"X Zhang","year":"2022","unstructured":"Zhang X, Ma Y, Ma J, Yang L, Song Q, Wang H, et al. Glutathione peroxidase 4 as a therapeutic target for anti-colorectal cancer drug-tolerant persister cells. Front Oncol. 2022;12:913669.","journal-title":"Front Oncol"},{"issue":"4","key":"895_CR45","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s42255-020-0191-z","volume":"2","author":"DB Fox","year":"2020","unstructured":"Fox DB, Garcia NMG, McKinney BJ, Lupo R, Noteware LC, Newcomb R, et al. NRF2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism. Nat Metab. 2020;2(4):318\u201334.","journal-title":"Nat Metab"},{"issue":"17","key":"895_CR46","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1007\/s00018-018-2790-3","volume":"75","author":"SJ Collins","year":"2018","unstructured":"Collins SJ, Tumpach C, Groveman BR, Drew SC, Haigh CL. Prion protein cleavage fragments regulate adult neural stem cell quiescence through redox modulation of mitochondrial fission and SOD2 expression. Cell Mol Life Sci. 2018;75(17):3231\u201349.","journal-title":"Cell Mol Life Sci"},{"key":"895_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102707","author":"B Li","year":"2021","unstructured":"Li B, Huang Y, Ming H, Nice EC, Xuan R, Huang C. Redox control of the dormant cancer cell life cycle. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10102707.","journal-title":"Cells"},{"issue":"1","key":"895_CR48","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.trecan.2018.10.010","volume":"5","author":"C Prunier","year":"2019","unstructured":"Prunier C, Baker D, ten Dijke P, Ritsma L. TGF-\u03b2 family signaling pathways in cellular dormancy. Trends Cancer. 2019;5(1):66\u201378.","journal-title":"Trends Cancer"},{"issue":"8","key":"895_CR49","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41580-019-0134-2","volume":"20","author":"JZ Kechagia","year":"2019","unstructured":"Kechagia JZ, Ivaska J, Roca-Cusachs P. Integrins as biomechanical sensors of the microenvironment. Nat Rev Mol Cell Biol. 2019;20(8):457\u201373.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"895_CR50","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41568-020-00312-2","volume":"21","author":"X Chen","year":"2021","unstructured":"Chen X, Cubillos-Ruiz JR. Endoplasmic reticulum stress signals in the tumour and its microenvironment. Nat Rev Cancer. 2021;21(2):71\u201388.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"895_CR51","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","volume":"21","author":"C Hetz","year":"2020","unstructured":"Hetz C, Zhang K, Kaufman RJ. Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol. 2020;21(8):421\u201338.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"895_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20246309","author":"D Lee","year":"2019","unstructured":"Lee D, Hokinson D, Park S, Elvira R, Kusuma F, Lee J-M, et al. ER stress induces cell cycle arrest at the G2\/M phase through eIF2\u03b1 phosphorylation and GADD45\u03b1. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20246309.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"895_CR53","doi-asserted-by":"publisher","first-page":"669","DOI":"10.7150\/jca.61622","volume":"13","author":"XG Zheng","year":"2022","unstructured":"Zheng XG, Liu BT, Liu XX, Li P, Zhang PC, Ye F, et al. PERK regulates the sensitivity of hepatocellular carcinoma cells to high-LET carbon ions via either apoptosis or ferroptosis. J Cancer. 2022;13(2):669\u201380.","journal-title":"J Cancer"},{"issue":"8","key":"895_CR54","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.trecan.2016.06.004","volume":"2","author":"D Senft","year":"2016","unstructured":"Senft D, Ronai ZeA. Adaptive stress responses during tumor metastasis and dormancy. Trends Cancer. 2016;2(8):429\u201342.","journal-title":"Trends Cancer"},{"key":"895_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101512","author":"K Schroeder","year":"2020","unstructured":"Schroeder K. NADPH oxidases: current aspects and tools. Redox Biol. 2020. https:\/\/doi.org\/10.1016\/j.redox.2020.101512.","journal-title":"Redox Biol"},{"issue":"1","key":"895_CR56","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1158\/1541-7786.MCR-19-0691","volume":"18","author":"W-H Yang","year":"2020","unstructured":"Yang W-H, Huang Z, Wu J, Ding C-KC, Murphy SK, Chi J-T. A TAZ-ANGPTL4-NOX2 axis regulates ferroptotic cell death and chemoresistance in epithelial ovarian cancer. Mol Cancer Res. 2020;18(1):79\u201390.","journal-title":"Mol Cancer Res"},{"key":"895_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001326","author":"W Lu","year":"2012","unstructured":"Lu W, Hu Y, Chen G, Chen Z, Zhang H, Wang F, et al. Novel role of NOX in supporting aerobic glycolysis in cancer cells with mitochondrial dysfunction and as a potential target for cancer therapy. PLoS Biol. 2012. https:\/\/doi.org\/10.1371\/journal.pbio.1001326.","journal-title":"PLoS Biol"},{"key":"895_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122002","author":"K Bertram","year":"2015","unstructured":"Bertram K, Valcu C-M, Weitnauer M, Linne U, Goerlach A. NOX1 supports the metabolic remodeling of HepG2 cells. PLoS ONE. 2015. https:\/\/doi.org\/10.1371\/journal.pone.0122002.","journal-title":"PLoS ONE"},{"key":"895_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112519","author":"H Ohata","year":"2023","unstructured":"Ohata H, Shiokawa D, Sakai H, Kanda Y, Okimoto Y, Kaneko S, et al. PROX1 induction by autolysosomal activity stabilizes persister-like state of colon cancer via feedback repression of the NOX1-mTORC1 pathway. Cell Rep. 2023. https:\/\/doi.org\/10.1016\/j.celrep.2023.112519.","journal-title":"Cell Rep"},{"issue":"2","key":"895_CR60","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00210-009-0413-0","volume":"380","author":"H Peshavariya","year":"2009","unstructured":"Peshavariya H, Dusting GJ, Jiang F, Halmos LR, Sobey CG, Drummond GR, et al. NADPH oxidase isoform selective regulation of endothelial cell proliferation and survival. Naunyn Schmied Arch Pharmacol. 2009;380(2):193\u2013204.","journal-title":"Naunyn Schmied Arch Pharmacol"},{"key":"895_CR61","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.freeradbiomed.2023.02.005","volume":"198","author":"M Romo-Gonzalez","year":"2023","unstructured":"Romo-Gonzalez M, Ijurko C, Alonso MT, de Cedron MG, de Molina AR, Soriano ME, et al. NOX2 and NOX4 control mitochondrial function in chronic myeloid leukaemia. Free Radic Biol Med. 2023;198:92\u2013108.","journal-title":"Free Radic Biol Med"},{"issue":"22","key":"895_CR62","doi-asserted-by":"publisher","first-page":"10823","DOI":"10.1158\/0008-5472.CAN-07-0783","volume":"67","author":"C Xia","year":"2007","unstructured":"Xia C, Meng Q, Lin L-Z, Rojanasakul Y, Wang X-R, Jiang B-H. Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. Cancer Res. 2007;67(22):10823\u201330.","journal-title":"Cancer Res"},{"issue":"9","key":"895_CR63","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1158\/0008-5472.CAN-19-3158","volume":"80","author":"K Ford","year":"2020","unstructured":"Ford K, Hanley CJ, Mellone M, Szyndralewiez C, Heitz F, Wiesel P, et al. NOX4 inhibition potentiates immunotherapy by overcoming cancer-associated fibroblast-mediated CD8 T-cell exclusion from tumors. Cancer Res. 2020;80(9):1846\u201360.","journal-title":"Cancer Res"},{"key":"895_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071647","author":"W-J Liu","year":"2021","unstructured":"Liu W-J, Huang Y-X, Wang W, Zhang Y, Liu B-J, Qiu J-G, et al. Nox4 signaling mediates cancer development and therapeutic resistance through HER3 in ovarian cancer cells. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10071647.","journal-title":"Cells"},{"key":"895_CR65","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2019.30.e75","author":"YW Chung","year":"2019","unstructured":"Chung YW, Kim S, Hong JH, Lee JK, Lee NW, Lee YS, et al. Overexpression of HER2\/HER3 and clinical feature of ovarian cancer. J Gynecol Oncol. 2019. https:\/\/doi.org\/10.3802\/jgo.2019.30.e75.","journal-title":"J Gynecol Oncol"},{"issue":"4","key":"895_CR66","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/ijc.23569","volume":"123","author":"T Shono","year":"2008","unstructured":"Shono T, Yokoyama N, Uesaka T, Kuroda J, Takeya R, Yamasaki T, et al. Enhanced expression of NADPH oxidase Nox4 in human gliomas and its roles in cell proliferation and survival. Int J Cancer. 2008;123(4):787\u201392.","journal-title":"Int J Cancer"},{"key":"895_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101107","author":"M Dodson","year":"2019","unstructured":"Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 2019. https:\/\/doi.org\/10.1016\/j.redox.2019.101107.","journal-title":"Redox Biol"},{"issue":"20","key":"895_CR68","doi-asserted-by":"publisher","first-page":"13291","DOI":"10.1074\/jbc.R900010200","volume":"284","author":"T Nguyen","year":"2009","unstructured":"Nguyen T, Nioi P, Pickett CB. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem. 2009;284(20):13291\u20135.","journal-title":"J Biol Chem"},{"issue":"4","key":"895_CR69","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.chembiol.2020.03.011","volume":"27","author":"A Anandhan","year":"2020","unstructured":"Anandhan A, Dodson M, Schmidlin CJ, Liu P, Zhang DD. Breakdown of an ironclad defense system: the critical role of NRF2 in mediating ferroptosis. Cell Chem Biol. 2020;27(4):436\u201347.","journal-title":"Cell Chem Biol"},{"key":"895_CR70","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.freeradbiomed.2018.10.426","volume":"129","author":"D Shin","year":"2018","unstructured":"Shin D, Kim EH, Lee J, Roh J-L. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer. Free Radic Biol Med. 2018;129:454\u201362.","journal-title":"Free Radic Biol Med"},{"key":"895_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202308241","author":"L Qiao","year":"2024","unstructured":"Qiao L, Zhu G, Jiang T, Qian Y, Sun Q, Zhao G, et al. Self-destructive copper carriers induce pyroptosis and cuproptosis for efficient tumor immunotherapy against dormant and recurrent tumors. Adv Mater. 2024. https:\/\/doi.org\/10.1002\/adma.202308241.","journal-title":"Adv Mater"},{"key":"895_CR72","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.18970","volume":"6","author":"EB Krail","year":"2017","unstructured":"Krail EB, Wang B, Munoz DM, Ilic N, Raghavan S, Niederst MJ, et al. KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer. Elife. 2017;6:e18970.","journal-title":"Elife"},{"issue":"33","key":"895_CR73","doi-asserted-by":"publisher","first-page":"25733","DOI":"10.1074\/jbc.M002740200","volume":"275","author":"ME Cockman","year":"2000","unstructured":"Cockman ME, Masson N, Mole DR, Jaakkola P, Chang GW, Clifford SC, et al. Hypoxia inducible factor-\u03b1 binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J Biol Chem. 2000;275(33):25733\u201341.","journal-title":"J Biol Chem"},{"issue":"12","key":"895_CR74","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1101\/gad.991402","volume":"16","author":"D Lando","year":"2002","unstructured":"Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 2002;16(12):1466\u201371.","journal-title":"Genes Dev"},{"issue":"8","key":"895_CR75","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1242\/jcs.112.8.1203","volume":"112","author":"D Chilov","year":"1999","unstructured":"Chilov D, Camenisch G, Kvietikova I, Ziegler U, Gassmann M, Wenger RH. Induction and nuclear translocation of hypoxia-inducible factor-1 (HIF-1): heterodimerization with ARNT is not necessary for nuclear accumulation of HIF-1\u03b1. J Cell Sci. 1999;112(8):1203\u201312.","journal-title":"J Cell Sci"},{"issue":"5516","key":"895_CR76","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1126\/science.1059817","volume":"292","author":"M Ivan","year":"2001","unstructured":"Ivan M, Kondo K, Yang HF, Kim W, Valiando J, Ohh M, et al. HIF\u03b1 targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science. 2001;292(5516):464\u20138.","journal-title":"Science"},{"key":"895_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01285-4","author":"S Ju","year":"2020","unstructured":"Ju S, Wang F, Wang Y, Ju S. CSN8 is a key regulator in hypoxia-induced epithelial\u2013mesenchymal transition and dormancy of colorectal cancer cells. Mol Cancer. 2020. https:\/\/doi.org\/10.1186\/s12943-020-01285-4.","journal-title":"Mol Cancer"},{"issue":"6","key":"895_CR78","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1182\/blood.2022018196","volume":"142","author":"S Qiu","year":"2023","unstructured":"Qiu S, Sheth V, Yan C, Liu J, Chacko BK, Li H, et al. Metabolic adaptation to tyrosine kinase inhibition in leukemia stem cells. Blood. 2023;142(6):574\u201388.","journal-title":"Blood"},{"key":"895_CR79","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1608806","author":"J Xiong","year":"2022","unstructured":"Xiong J, Nie M, Fu C, Chai X, Zhang Y, He L, et al. Hypoxia enhances HIF1\u03b1 transcription activity by upregulating KDM4A and mediating H3K9me3, thus inducing ferroptosis resistance in cervical cancer cells. Stem Cells Int. 2022. https:\/\/doi.org\/10.1155\/2022\/1608806.","journal-title":"Stem Cells Int"},{"key":"895_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.626390","author":"X Feng","year":"2021","unstructured":"Feng X, Wang S, Sun Z, Dong H, Yu H, Huang M, et al. Ferroptosis enhanced diabetic renal tubular injury via HIF-1\u03b1\/HO-1 pathway in db\/db mice. Front Endocrinol (Lausanne). 2021. https:\/\/doi.org\/10.3389\/fendo.2021.626390.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"895_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102312","author":"Z Lin","year":"2022","unstructured":"Lin Z, Song J, Gao Y, Huang S, Dou R, Zhong P, et al. Hypoxia-induced HIF-1\u03b1\/lncRNA-PMAN inhibits ferroptosis by promoting the cytoplasmic translocation of ELAVL1 in peritoneal dissemination from gastric cancer. Redox Biol. 2022. https:\/\/doi.org\/10.1016\/j.redox.2022.102312.","journal-title":"Redox Biol"},{"issue":"3","key":"895_CR82","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/path.4838","volume":"241","author":"C-H Hsieh","year":"2017","unstructured":"Hsieh C-H, Lin Y-J, Chen W-L, Huang Y-C, Chang C-W, Cheng F-C, et al. HIF-1 triggers long-lasting glutamate excitotoxicity via system Xc\u2212 in cerebral ischaemia-reperfusion. J Pathol. 2017;241(3):337\u201349.","journal-title":"J Pathol"},{"key":"895_CR83","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.canlet.2017.12.025","volume":"416","author":"L-C Chang","year":"2018","unstructured":"Chang L-C, Chiang S-K, Chen S-E, Yu Y-L, Chou R-H, Chang W-C. Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis. Cancer Lett. 2018;416:124\u201337.","journal-title":"Cancer Lett"},{"issue":"1","key":"895_CR84","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/hep.28251","volume":"63","author":"X Sun","year":"2016","unstructured":"Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R, et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 2016;63(1):173\u201384.","journal-title":"Hepatology"},{"issue":"13","key":"895_CR85","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1096\/fasebj.13.13.1800","volume":"13","author":"DM Suttner","year":"1999","unstructured":"Suttner DM, Dennery PA. Reversal of HO-1 related cytoprotection with increased expression is due to reactive iron. FASEB J. 1999;13(13):1800\u20139.","journal-title":"FASEB J"},{"issue":"12","key":"895_CR86","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1089\/ars.2012.4935","volume":"20","author":"Y Du","year":"2014","unstructured":"Du Y, Xia Y, Pan X, Chen Z, Wang A, Wang K, et al. Fenretinide targets chronic myeloid leukemia stem\/progenitor cells by regulation of redox signaling. Antioxid Redox Signal. 2014;20(12):1866\u201380.","journal-title":"Antioxid Redox Signal"},{"key":"895_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101360","author":"Y Yang","year":"2022","unstructured":"Yang Y, Tang H, Zheng J, Yang K. The PER1\/HIF-1alpha negative feedback loop promotes ferroptosis and inhibits tumor progression in oral squamous cell carcinoma. Transl Oncol. 2022. https:\/\/doi.org\/10.1016\/j.tranon.2022.101360.","journal-title":"Transl Oncol"},{"key":"895_CR88","doi-asserted-by":"publisher","DOI":"10.1172\/JCI143691","author":"R Singhal","year":"2021","unstructured":"Singhal R, Mitta SR, Das NK, Kerk SA, Sajjakulnukit P, Solanki S, et al. HIF-2\u03b1 activation potentiates oxidative cell death in colorectal cancers by increasing cellular iron. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/JCI143691.","journal-title":"J Clin Invest"},{"key":"895_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112945","author":"Z Yang","year":"2023","unstructured":"Yang Z, Su W, Wei X, Qu S, Zhao D, Zhou J, et al. HIF-1a drives resistance to ferroptosis in solid tumors by promoting lactate production and activating SLC1A1. Cell Rep. 2023. https:\/\/doi.org\/10.1016\/j.celrep.2023.112945.","journal-title":"Cell Rep"},{"issue":"3","key":"895_CR90","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.cell.2017.11.048","volume":"172","author":"I Ingold","year":"2018","unstructured":"Ingold I, Berndt C, Schmitt S, Doll S, Poschmann G, Buday K, et al. Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis. Cell. 2018;172(3):409\u201322.","journal-title":"Cell"},{"key":"895_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/nature24297","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer MJ, Viswanathan VS, Ryan MJ, Bole D, Eaton J, Schreiber SL, et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Cancer Res. 2017. https:\/\/doi.org\/10.1038\/nature24297.","journal-title":"Cancer Res"},{"key":"895_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2019.08.004","author":"B Hassannia","year":"2020","unstructured":"Hassannia B, Logie E, Vandenabeele P, Vanden Berghe T, Vanden Berghe W. Withaferin A: from ayurvedic folk medicine to preclinical anti-cancer drug. Biochem Pharmacol. 2020. https:\/\/doi.org\/10.1016\/j.bcp.2019.08.004.","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"895_CR93","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1172\/JCI99032","volume":"128","author":"B Hassannia","year":"2018","unstructured":"Hassannia B, Wiernicki B, Ingold I, Qu F, Van Herck S, Tyurina YY, et al. Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma. J Clin Invest. 2018;128(8):3341\u201355.","journal-title":"J Clin Invest"},{"issue":"7","key":"895_CR94","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22(7):381\u201396.","journal-title":"Nat Rev Cancer"},{"issue":"7664","key":"895_CR95","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan VS, Ryan MJ, Dhruv HD, Gill S, Eichhoff OM, Seashore-Ludlow B, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017;547(7664):453\u20137.","journal-title":"Nature"},{"issue":"8","key":"895_CR96","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1158\/0008-5472.CAN-07-5957","volume":"68","author":"DM Townsend","year":"2008","unstructured":"Townsend DM, He L, Hutchens S, Garrett TE, Pazoles CJ, Tew KD. NOV-002, a glutathione disulfide mimetic, as a modulator of cellular redox balance. Cancer Res. 2008;68(8):2870\u20137.","journal-title":"Cancer Res"},{"issue":"4","key":"895_CR97","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.molcel.2021.12.001","volume":"82","author":"R Rodriguez","year":"2022","unstructured":"Rodriguez R, Schreiber SL, Conrad M. Persister cancer cells: iron addiction and vulnerability to ferroptosis. Mol Cell. 2022;82(4):728\u201340.","journal-title":"Mol Cell"},{"issue":"16","key":"895_CR98","doi-asserted-by":"publisher","first-page":"15328","DOI":"10.1021\/acsnano.3c04632","volume":"17","author":"H Yang","year":"2023","unstructured":"Yang H, Yao X, Liu Y, Shen X, Li M, Luo Z. Ferroptosis nanomedicine: clinical challenges and opportunities for modulating tumor metabolic and immunological landscape. ACS Nano. 2023;17(16):15328\u201353.","journal-title":"ACS Nano"},{"issue":"5","key":"895_CR99","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cmet.2020.09.001","volume":"32","author":"D Forte","year":"2020","unstructured":"Forte D, Garcia-Fernandez M, Sanchez-Aguilera A, Stavropoulou V, Fielding C, Martin-Perez D, et al. Bone marrow mesenchymal stem cells support acute myeloid leukemia bioenergetics and enhance antioxidant defense and escape from chemotherapy. Cell Metab. 2020;32(5):829\u201343.","journal-title":"Cell Metab"},{"issue":"11","key":"895_CR100","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/ncb2861","volume":"15","author":"P Bragado","year":"2013","unstructured":"Bragado P, Estrada Y, Parikh F, Krause S, Capobianco C, Farina HG, et al. TGF-\u03b22 dictates disseminated tumour cell fate in target organs through TGF-\u03b2-RIII and p38\u03b1\/\u03b2 signalling. Nat Cell Biol. 2013;15(11):1351\u201361.","journal-title":"Nat Cell Biol"},{"issue":"11","key":"895_CR101","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1158\/0008-5472.CAN-17-1051","volume":"78","author":"L-Y Yu-Lee","year":"2018","unstructured":"Yu-Lee L-Y, Yu G, Lee Y-C, Lin S-C, Pan J, Pan T, et al. Osteoblast-secreted factors mediate dormancy of metastatic prostate cancer in the bone via activation of the TGF\u03b2RIII-p38MAPK-pS249\/T252RB pathway. Cancer Res. 2018;78(11):2911\u201324.","journal-title":"Cancer Res"},{"issue":"7","key":"895_CR102","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/ncb2767","volume":"15","author":"CM Ghajar","year":"2013","unstructured":"Ghajar CM, Peinado H, Mori H, Matei IR, Evason KJ, Brazier H, et al. The perivascular niche regulates breast tumour dormancy. Nat Cell Biol. 2013;15(7):807\u201317.","journal-title":"Nat Cell Biol"},{"key":"895_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.09.016","author":"E Dalla","year":"2024","unstructured":"Dalla E, Papanicolaou M, Park MD, Barth N, Hou R, Segura-Villalobos D, et al. Lung-resident alveolar macrophages regulate the timing of breast cancer metastasis. Cell. 2024. https:\/\/doi.org\/10.1016\/j.cell.2024.09.016.","journal-title":"Cell"},{"key":"895_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-025-01094-y","author":"Z Wang","year":"2026","unstructured":"Wang Z, Elbanna Y, Godet I, Peters L, Lampe G, Chen Y, et al. TGF-beta induces an atypical EMT to evade immune mechanosurveillance in lung adenocarcinoma dormant metastasis. Nat Cancer. 2026. https:\/\/doi.org\/10.1038\/s43018-025-01094-y.","journal-title":"Nat Cancer."},{"issue":"10","key":"895_CR105","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/ncb1780","volume":"10","author":"A Sorrentino","year":"2008","unstructured":"Sorrentino A, Thakur N, Grimsby S, Marcusson A, von Bulow V, Schuster N, et al. The type I TGF-\u03b2 receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol. 2008;10(10):1199\u2013207.","journal-title":"Nat Cell Biol"},{"issue":"31","key":"895_CR106","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.1038\/onc.2015.471","volume":"35","author":"JE Kim","year":"2016","unstructured":"Kim JE, Roh E, Lee MH, Yu DH, Kim DJ, Lim TG, et al. Fyn is a redox sensor involved in solar ultraviolet light-induced signal transduction in skin carcinogenesis. Oncogene. 2016;35(31):4091\u2013101.","journal-title":"Oncogene"},{"key":"895_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10060872","author":"J Lee","year":"2021","unstructured":"Lee J, Song C-H. Effect of reactive oxygen species on the endoplasmic reticulum and mitochondria during intracellular pathogen infection of mammalian cells. Antioxidants. 2021. https:\/\/doi.org\/10.3390\/antiox10060872.","journal-title":"Antioxidants"},{"issue":"2","key":"895_CR108","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1096\/fj.201800836R","volume":"33","author":"HS Kim","year":"2019","unstructured":"Kim HS, Kim Y, Lim MJ, Park Y-G, Park SI, Sohn J. The p38-activated ER stress-ATF6 axis mediates cellular senescence. FASEB J. 2019;33(2):2422\u201334.","journal-title":"FASEB J"},{"key":"895_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7170","author":"MS Sosa","year":"2015","unstructured":"Sosa MS, Parikh F, Maia AG, Estrada Y, Bosch A, Bragado P, et al. NR2F1 controls tumour cell dormancy via SOX9-and RAR\u03b2-driven quiescence programmes. Nat Commun. 2015. https:\/\/doi.org\/10.1038\/ncomms7170.","journal-title":"Nat Commun"},{"issue":"1","key":"895_CR110","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1083\/jcb.137.1.231","volume":"137","author":"VM Weaver","year":"1997","unstructured":"Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, et al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol. 1997;137(1):231\u201345.","journal-title":"J Cell Biol"},{"issue":"2","key":"895_CR111","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ccr.2004.06.025","volume":"6","author":"DE White","year":"2004","unstructured":"White DE, Kurpios NA, Zuo DM, Hassell JA, Blaess S, Mueller U, et al. Targeted disruption of \u03b21-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell. 2004;6(2):159\u201370.","journal-title":"Cancer Cell"},{"issue":"12","key":"895_CR112","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.21037\/tlcr-23-707","volume":"12","author":"X Feng","year":"2023","unstructured":"Feng X, Liu X, Xiang J, Xu J, Yin N, Wang L, et al. Exosomal ITGB6 from dormant lung adenocarcinoma cells activates cancer-associated fibroblasts by KLF10 positive feedback loop and the TGF-\u03b2 pathway. Transl Lung Cancer Res. 2023;12(12):2520\u201337.","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"895_CR113","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s43018-021-00291-9","volume":"3","author":"JS Di Martino","year":"2022","unstructured":"Di Martino JS, Nobre AR, Mondal C, Taha I, Farias EF, Fertig EJ, et al. A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy. Nature Cancer. 2022;3(1):90\u2013107.","journal-title":"Nature Cancer"},{"key":"895_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.08.012","author":"SS Watson","year":"2024","unstructured":"Watson SS, Zomer A, Fournier N, Lourenco J, Quadroni M, Chryplewicz A, et al. Fibrotic response to anti-CSF-1R therapy potentiates glioblastoma recurrence. Cancer Cell. 2024. https:\/\/doi.org\/10.1016\/j.ccell.2024.08.012.","journal-title":"Cancer Cell"},{"issue":"9","key":"895_CR115","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1002\/1878-0261.13200","volume":"16","author":"P Garcia-Gomez","year":"2022","unstructured":"Garcia-Gomez P, Golan I, Dadras MS, Mezheyeuski A, Bellomo C, Tzavlaki K, et al. Nox4 regulates TGF\u03b2-induced proliferation and self-renewal in glioblastoma stem cells. Mol Oncol. 2022;16(9):1891\u2013912.","journal-title":"Mol Oncol"},{"issue":"3","key":"895_CR116","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","volume":"23","author":"Y Xie","year":"2016","unstructured":"Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X, et al. Ferroptosis: process and function. Cell Death Differ. 2016;23(3):369\u201379.","journal-title":"Cell Death Differ"},{"issue":"4","key":"895_CR117","doi-asserted-by":"publisher","first-page":"e1054549","DOI":"10.1080\/23723556.2015.1054549","volume":"2","author":"Y Yu","year":"2015","unstructured":"Yu Y, Xie Y, Cao L, Yang L, Yang M, Lotze MT, et al. The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. Molecular & Cellular Oncology. 2015;2(4):e1054549-e.","journal-title":"Molecular & Cellular Oncology"},{"issue":"11","key":"895_CR118","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1016\/j.celrep.2017.02.054","volume":"18","author":"I Poursaitidis","year":"2017","unstructured":"Poursaitidis I, Wang X, Crighton T, Labuschagne C, Mason D, Cramer SL, et al. Oncogene-selective sensitivity to synchronous cell death following modulation of the amino acid nutrient cystine. Cell Rep. 2017;18(11):2547\u201356.","journal-title":"Cell Rep"},{"issue":"3","key":"895_CR119","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41401-020-0457-8","volume":"42","author":"X-m Jiang","year":"2021","unstructured":"Jiang X-m, Xu Y-l, Yuan L-w, Zhang L-l, Huang M-y, Ye Z-h, et al. Tgf\u03b22-mediated epithelial-mesenchymal transition and NF-\u03baB pathway activation contribute to osimertinib resistance. Acta Pharmacol Sin. 2021;42(3):451\u20139.","journal-title":"Acta Pharmacol Sin"},{"issue":"12","key":"895_CR120","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1002\/1878-0261.13215","volume":"16","author":"Y Tsubakihara","year":"2022","unstructured":"Tsubakihara Y, Ohata Y, Okita Y, Younis S, Eriksson J, Sellin ME, et al. Tgf\u03b2 selects for pro-stemness over pro-invasive phenotypes during cancer cell epithelial\u2013mesenchymal transition. Mol Oncol. 2022;16(12):2330\u201354.","journal-title":"Mol Oncol"},{"issue":"5","key":"895_CR121","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41419-020-2618-6","volume":"11","author":"DH Kim","year":"2020","unstructured":"Kim DH, Kim WD, Kim SK, Moon DH, Lee SJ. TGF-\u03b21-mediated repression of SLC7A11 drives vulnerability to GPX4 inhibition in hepatocellular carcinoma cells. Cell Death Dis. 2020;11(5):406.","journal-title":"Cell Death Dis"},{"issue":"2","key":"895_CR122","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/JLB.3MA1220-815RRR","volume":"110","author":"R Kong","year":"2021","unstructured":"Kong R, Wang N, Han W, Bao W, Lu J. Ifn\u03b3-mediated repression of system Xc\u2212 drives vulnerability to induced ferroptosis in hepatocellular carcinoma cells. J Leukoc Biol. 2021;110(2):301\u201314.","journal-title":"J Leukoc Biol"},{"key":"895_CR123","doi-asserted-by":"publisher","first-page":"106915","DOI":"10.1016\/j.phrs.2023.106915","volume":"196","author":"W Bao","year":"2023","unstructured":"Bao W, Wang J, Fan K, Gao Y, Chen J. PIAS3 promotes ferroptosis by regulating TXNIP via TGF-\u03b2 signaling pathway in hepatocellular carcinoma. Pharmacol Res. 2023;196:106915.","journal-title":"Pharmacol Res"},{"issue":"6","key":"895_CR124","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s10637-021-01114-5","volume":"39","author":"C-j Qiu","year":"2021","unstructured":"Qiu C-j, Wang X-b, Zheng Z-r, Yang C-z, Lin K, Zhang K, et al. Development and validation of a ferroptosis-related prognostic model in pancreatic cancer. Invest New Drugs. 2021;39(6):1507\u201322.","journal-title":"Invest New Drugs"},{"issue":"4","key":"895_CR125","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s41401-023-01199-z","volume":"45","author":"HD Chen","year":"2024","unstructured":"Chen HD, Ye Z, Hu HF, Fan GX, Hu YH, Li Z, et al. SMAD4 endows TGF-\u03b21-induced highly invasive tumor cells with ferroptosis vulnerability in pancreatic cancer. Acta Pharmacol Sin. 2024;45(4):844\u201356.","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"895_CR126","doi-asserted-by":"publisher","first-page":"112560","DOI":"10.1016\/j.celrep.2023.112560","volume":"42","author":"DK Singh","year":"2023","unstructured":"Singh DK, Carcamo S, Farias EF, Hasson D, Zheng W, Sun D, et al. 5-Azacytidine- and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-\u03b2-SMAD4 signaling. Cell Rep. 2023;42(6):112560.","journal-title":"Cell Rep"},{"key":"895_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115592","author":"P Huang","year":"2023","unstructured":"Huang P, Zhao H, Pan X, Li J, Pan W, Dai H, et al. SIRT3-mediated autophagy contributes to ferroptosis-induced anticancer by inducing the formation of BECN1-SLC7A11 complex. Biochem Pharmacol. 2023. https:\/\/doi.org\/10.1016\/j.bcp.2023.115592.","journal-title":"Biochem Pharmacol"},{"key":"895_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01223-x","author":"H Li","year":"2022","unstructured":"Li H, Yang P, Wang J, Zhang J, Ma Q, Jiang Y, et al. HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk. J Hematol Oncol. 2022. https:\/\/doi.org\/10.1186\/s13045-021-01223-x.","journal-title":"J Hematol Oncol"},{"issue":"5","key":"895_CR129","doi-asserted-by":"publisher","first-page":"5662","DOI":"10.1021\/acsnano.9b00892","volume":"13","author":"F Zhang","year":"2019","unstructured":"Zhang F, Li F, Lu G-H, Nie W, Zhang L, Lv Y, et al. Engineering magnetosomes for ferroptosis\/immunomodulation synergism in cancer. ACS Nano. 2019;13(5):5662\u201373.","journal-title":"ACS Nano"},{"issue":"7635","key":"895_CR130","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature20791","volume":"541","author":"G Pascual","year":"2017","unstructured":"Pascual G, Avgustinova A, Mejetta S, Martin M, Castellanos A, Stephan-Otto Attolini C, et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature. 2017;541(7635):41\u20135.","journal-title":"Nature"},{"key":"895_CR131","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau5758","author":"MJ Watt","year":"2019","unstructured":"Watt MJ, Clark AK, Selth LA, Haynes VR, Lister N, Rebello R, et al. Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer. Sci Transl Med. 2019. https:\/\/doi.org\/10.1126\/scitranslmed.aau5758.","journal-title":"Sci Transl Med"},{"key":"895_CR132","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0646-3","author":"X Luo","year":"2017","unstructured":"Luo X, Cheng C, Tan Z, Li N, Tang M, Yang L, et al. Emerging roles of lipid metabolism in cancer metastasis. Mol Cancer. 2017. https:\/\/doi.org\/10.1186\/s12943-017-0646-3.","journal-title":"Mol Cancer"},{"issue":"1","key":"895_CR133","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1172\/JCI58128","volume":"122","author":"D Panigrahy","year":"2012","unstructured":"Panigrahy D, Edin ML, Lee CR, Huang S, Bielenberg DR, Butterfield CE, et al. Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice. J Clin Investig. 2012;122(1):178\u201391.","journal-title":"J Clin Investig"},{"issue":"7","key":"895_CR134","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1021\/acschembio.5b00245","volume":"10","author":"SJ Dixon","year":"2015","unstructured":"Dixon SJ, Winter GE, Musavi LS, Lee ED, Snijder B, Rebsamen M, et al. Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death. ACS Chem Biol. 2015;10(7):1604\u20139.","journal-title":"ACS Chem Biol"},{"issue":"1","key":"895_CR135","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, IngoId I, et al. Acsl4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13(1):91\u20138.","journal-title":"Nat Chem Biol"},{"issue":"10","key":"895_CR136","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1016\/j.celrep.2018.08.015","volume":"24","author":"D Ackerman","year":"2018","unstructured":"Ackerman D, Tumanov S, Qiu B, Michalopoulou E, Spata M, Azzam A, et al. Triglycerides promote lipid homeostasis during hypoxic stress by balancing fatty acid saturation. Cell Rep. 2018;24(10):2596\u2013605.","journal-title":"Cell Rep"},{"issue":"5","key":"895_CR137","doi-asserted-by":"publisher","first-page":"5683","DOI":"10.1002\/jcp.27411","volume":"234","author":"NH Goradel","year":"2019","unstructured":"Goradel NH, Najafi M, Salehi E, Farhood B, Mortezaee K. Cyclooxygenase-2 in cancer: a review. J Cell Physiol. 2019;234(5):5683\u201399.","journal-title":"J Cell Physiol"},{"issue":"3","key":"895_CR138","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/carcin\/bgp014","volume":"30","author":"A Greenhough","year":"2009","unstructured":"Greenhough A, Smartt HJM, Moore AE, Roberts HR, Williams AC, Paraskeva C, et al. The COX-2\/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis. 2009;30(3):377\u201386.","journal-title":"Carcinogenesis"},{"key":"895_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110389","author":"S Li","year":"2020","unstructured":"Li S, Jiang M, Wang L, Yu S. Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers: recent advancement. Biomed Pharmacother. 2020. https:\/\/doi.org\/10.1016\/j.biopha.2020.110389.","journal-title":"Biomed Pharmacother"},{"issue":"15","key":"895_CR140","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1158\/1078-0432.CCR-11-3348","volume":"18","author":"L-Y Chung","year":"2012","unstructured":"Chung L-Y, Tang S-J, Sun G-H, Chou T-Y, Yeh T-S, Yu S-L, et al. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2. Clin Cancer Res. 2012;18(15):4037\u201347.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"895_CR141","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3748\/wjg.v11.i2.204","volume":"11","author":"D-S Huang","year":"2005","unstructured":"Huang D-S, Shen K-Z, Wei J-F, Liang T-B, Zheng S-S, Xie H-Y. Specific COX-2 inhibitor NS398 induces apoptosis in human liver cancer cell line HepG2 through BCL-2. World J Gastroenterol. 2005;11(2):204\u20137.","journal-title":"World J Gastroenterol"},{"key":"895_CR142","doi-asserted-by":"publisher","DOI":"10.3390\/cells8111453","author":"P Santofimia-Casta\u00f1o","year":"2019","unstructured":"Santofimia-Casta\u00f1o P, Xia Y, Peng L, Vel\u00e1zquez-Campoy A, Abi\u00e1n O, Lan W, et al. Targeting the stress-induced protein NUPR1 to treat pancreatic adenocarcinoma. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8111453.","journal-title":"Cells"},{"issue":"10","key":"895_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.264","volume":"6","author":"LR Palam","year":"2015","unstructured":"Palam LR, Gore J, Craven KE, Wilson JL, Korc M. Integrated stress response is critical for gemcitabine resistance in pancreatic ductal adenocarcinoma. Cell Death Dis. 2015;6(10):e1913.","journal-title":"Cell Death Dis"},{"issue":"4","key":"895_CR144","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3892\/or.2011.1143","volume":"25","author":"K Tang","year":"2011","unstructured":"Tang K, Zhang Z, Bai Z, Ma X, Guo W, Wang Y. Enhancement of gemcitabine sensitivity in pancreatic cancer by co-regulation of dCK and p8 expression. Oncol Rep. 2011;25(4):963\u201370.","journal-title":"Oncol Rep"},{"key":"895_CR145","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-021-00662-2","author":"C Huang","year":"2021","unstructured":"Huang C, Santofimia-Castano P, Liu X, Xia Y, Peng L, Gotorbe C, et al. NUPR1 inhibitor ZZW-115 induces ferroptosis in a mitochondria-dependent manner. Cell Death Discov. 2021. https:\/\/doi.org\/10.1038\/s41420-021-00662-2.","journal-title":"Cell Death Discov"},{"key":"895_CR146","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-20904-2","author":"J Liu","year":"2021","unstructured":"Liu J, Song X, Kuang F, Zhang Q, Xie Y, Kang R, et al. NUPR1 is a critical repressor of ferroptosis. Nat Commun. 2021. https:\/\/doi.org\/10.1038\/s41467-021-20904-2.","journal-title":"Nat Commun"},{"issue":"12","key":"895_CR147","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1002\/ar.22571","volume":"295","author":"X Guo","year":"2012","unstructured":"Guo X, Wang W, Hu J, Feng K, Pan Y, Zhang L, et al. Lentivirus-mediated RNAi knockdown of NUPR1 inhibits human nonsmall cell lung cancer growth in vitro and in vivo. Anat Rec-Adv Integr Anat Evol Biol. 2012;295(12):2114\u201321.","journal-title":"Anat Rec-Adv Integr Anat Evol Biol"},{"issue":"7","key":"895_CR148","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.celrep.2017.07.055","volume":"20","author":"Y Xie","year":"2017","unstructured":"Xie Y, Zhu S, Song X, Sun X, Fan Y, Liu J, et al. The tumor suppressor p53 limits ferroptosis by blocking DPP4 activity. Cell Rep. 2017;20(7):1692\u2013704.","journal-title":"Cell Rep"},{"key":"895_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e22091","author":"J-H Kim","year":"2023","unstructured":"Kim J-H, Kang K-W, Park Y, Kim BS. CXCR2 inhibition overcomes ponatinib intolerance by eradicating chronic myeloid leukemic stem cells through PI3K\/Akt\/mTOR and dipeptidylpeptidase IV (CD26). Heliyon. 2023. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e22091.","journal-title":"Heliyon"},{"issue":"2","key":"895_CR150","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.toxlet.2013.07.022","volume":"222","author":"J Zhou","year":"2013","unstructured":"Zhou J, Li P, Xue X, He S, Kuang Y, Zhao H, et al. Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species. Toxicol Lett. 2013;222(2):139\u201345.","journal-title":"Toxicol Lett"},{"issue":"9","key":"895_CR151","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/onc.2016.291","volume":"36","author":"YX Jiang","year":"2017","unstructured":"Jiang YX, Yang SW, Li PA, Luo X, Li ZY, Hao YX, et al. The promotion of the transformation of quiescent gastric cancer stem cells by IL-17 and the underlying mechanisms. Oncogene. 2017;36(9):1256\u201364.","journal-title":"Oncogene"},{"key":"895_CR152","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-024-01878-7","author":"S Dwyer","year":"2024","unstructured":"Dwyer S, Ruth J, Seidel HE, Raz AA, Chodosh LA. Autophagy is required for mammary tumor recurrence by promoting dormant tumor cell survival following therapy. Breast Cancer Res. 2024. https:\/\/doi.org\/10.1186\/s13058-024-01878-7.","journal-title":"Breast Cancer Res"},{"issue":"10","key":"895_CR153","first-page":"944","volume":"34","author":"X Tan","year":"2024","unstructured":"Tan X, Yao S, Wang G, Peng L. Research on uPAR promoting proliferation, migration, and chemoresistance of pancreatic cancer by inhibiting autophagy via MAPK signaling. China Oncol. 2024;34(10):944\u201356.","journal-title":"China Oncol"},{"key":"895_CR154","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12020305","author":"Y Sun","year":"2024","unstructured":"Sun Y, Chen Y, Liu Z, Wang J, Bai J, Du R, et al. Mitophagy-mediated tumor dormancy protects cancer cells from chemotherapy. Biomedicines. 2024. https:\/\/doi.org\/10.3390\/biomedicines12020305.","journal-title":"Biomedicines"},{"key":"895_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120217","author":"Y Qiu","year":"2020","unstructured":"Qiu Y, Qiu S, Deng L, Nie L, Gong L, Liao X, et al. Biomaterial 3D collagen I gel culture model: a novel approach to investigate tumorigenesis and dormancy of bladder cancer cells induced by tumor microenvironment. Biomaterials. 2020. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120217.","journal-title":"Biomaterials"},{"issue":"9","key":"895_CR156","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1080\/15548627.2019.1704104","volume":"16","author":"H Wang","year":"2020","unstructured":"Wang H, Wang N, Xu D, Ma Q, Chen Y, Xu S, et al. Oxidation of multiple MiT\/TFE transcription factors links oxidative stress to transcriptional control of autophagy and lysosome biogenesis. Autophagy. 2020;16(9):1683\u201396.","journal-title":"Autophagy"},{"key":"895_CR157","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21829-6","author":"L-A Ligeon","year":"2021","unstructured":"Ligeon L-A, Pena-Francesch M, Vanoaica LD, Nunez NG, Talwar D, Dick TP, et al. Oxidation inhibits autophagy protein deconjugation from phagosomes to sustain MHC class II restricted antigen presentation. Nat Commun. 2021. https:\/\/doi.org\/10.1038\/s41467-021-21829-6.","journal-title":"Nat Commun"},{"issue":"10","key":"895_CR158","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1080\/15548627.2019.1709763","volume":"16","author":"X Zheng","year":"2020","unstructured":"Zheng X, Yang Z, Gu Q, Xia F, Fu Y, Liu P, et al. The protease activity of human ATG4B is regulated by reversible oxidative modification. Autophagy. 2020;16(10):1838\u201350.","journal-title":"Autophagy"},{"issue":"1","key":"895_CR159","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12967-024-06059-w","volume":"23","author":"X Liu","year":"2025","unstructured":"Liu X, Tuerxun H, Zhao Y, Li Y, Wen S, Li X, et al. Crosstalk between ferroptosis and autophagy: broaden horizons of cancer therapy. J Transl Med. 2025;23(1):18.","journal-title":"J Transl Med"},{"issue":"8","key":"895_CR160","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1073\/pnas.1819728116","volume":"116","author":"Z Wu","year":"2019","unstructured":"Wu Z, Geng Y, Lu X, Shi Y, Wu G, Zhang M, et al. Chaperone-mediated autophagy is involved in the execution of ferroptosis. Proc Natl Acad Sci USA. 2019;116(8):2996\u20133005.","journal-title":"Proc Natl Acad Sci USA"},{"key":"895_CR161","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.991612","volume":"9","author":"CB Trelford","year":"2022","unstructured":"Trelford CB, Dagnino L, Di Guglielmo GM. Transforming growth factor-\u03b2 in tumour development. Front Mol Biosci. 2022;9:991612.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"895_CR162","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01831-w","volume":"22","author":"Y Ren","year":"2023","unstructured":"Ren Y, Wang R, Weng S, Xu H, Zhang Y, Chen S, et al. Multifaceted role of redox pattern in the tumor immune microenvironment regarding autophagy and apoptosis. Mol Cancer. 2023;22(1):130.","journal-title":"Mol Cancer"},{"issue":"2","key":"895_CR163","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1124\/jpet.111.184341","volume":"339","author":"S Mei","year":"2011","unstructured":"Mei S, Ni HM, Manley S, Bockus A, Kassel KM, Luyendyk JP, et al. Differential roles of unsaturated and saturated fatty acids on autophagy and apoptosis in hepatocytes. J Pharmacol Exp Ther. 2011;339(2):487\u201398.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"895_CR164","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.bbrc.2018.12.039","volume":"508","author":"Y Bai","year":"2019","unstructured":"Bai Y, Meng L, Han L, Jia Y, Zhao Y, Gao H, et al. Lipid storage and lipophagy regulates ferroptosis. Biochem Biophys Res Commun. 2019;508(4):997\u20131003.","journal-title":"Biochem Biophys Res Commun"},{"key":"895_CR165","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1085581","volume":"13","author":"Z Lu","year":"2023","unstructured":"Lu Z, Xiao B, Chen W, Tang T, Zhuo Q, Chen X. The potential of ferroptosis combined with radiotherapy in cancer treatment. Front Oncol. 2023;13:1085581.","journal-title":"Front Oncol"},{"key":"895_CR166","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2147\/NSA.S550828","volume":"18","author":"M Szwed","year":"2025","unstructured":"Szwed M, Poczta-Krawczyk A, Bukowski K, Marczak A. Nanoparticle-mediated ferroptosis for cancer therapy: mechanisms and therapeutic strategies. Nanotechnol Sci Appl. 2025;18:445\u201370.","journal-title":"Nanotechnol Sci Appl"},{"key":"895_CR167","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.818453","volume":"10","author":"J Deng","year":"2022","unstructured":"Deng J, Zhou M, Liao T, Kuang W, Xia H, Yin Z, et al. Targeting cancer cell ferroptosis to reverse immune checkpoint inhibitor therapy resistance. Front Cell Dev Biol. 2022;10:818453.","journal-title":"Front Cell Dev Biol"},{"key":"895_CR168","doi-asserted-by":"publisher","DOI":"10.1177\/09603271221149663","volume":"42","author":"IP Taufani","year":"2023","unstructured":"Taufani IP, Situmorang JH, Febriansah R, Tasminatun S, Sunarno S, Yang LY, et al. Mitochondrial ROS induced by ML385, an Nrf2 inhibitor aggravates the ferroptosis induced by RSL3 in human lung epithelial BEAS-2B cells. Hum Exp Toxicol. 2023;42:9603271221149663.","journal-title":"Hum Exp Toxicol"},{"issue":"12","key":"895_CR169","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s12032-024-02483-6","volume":"41","author":"L Yan","year":"2024","unstructured":"Yan L, Hu H, Feng L, Li Z, Zheng C, Zhang J, et al. ML385 promotes ferroptosis and radiotherapy sensitivity by inhibiting the NRF2-SLC7A11 pathway in esophageal squamous cell carcinoma. Med Oncol. 2024;41(12):309.","journal-title":"Med Oncol"},{"issue":"6","key":"895_CR170","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.14565","volume":"103","author":"Y Wan","year":"2024","unstructured":"Wan Y, Cheng J, Gan D, He J, Chen A, Ma J, et al. Brusatol induces ferroptosis to inhibit hepatocellular carcinoma progression by targeting ATF3. Chem Biol Drug Des. 2024;103(6):e14565.","journal-title":"Chem Biol Drug Des"},{"key":"895_CR171","doi-asserted-by":"publisher","DOI":"10.2174\/0113816128383328250808123933","author":"H Liu","year":"2025","unstructured":"Liu H, Wang L, Hu M, Hua J, Lian X, Lian C, et al. Brusatol regulates ferroptosis of ovarian cancer through the Nrf2\/HO-1\/NQO1 and AKT\/mTOR double signaling pathways. Curr Pharm Des. 2025. https:\/\/doi.org\/10.2174\/0113816128383328250808123933.","journal-title":"Curr Pharm Des"},{"key":"895_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115567","volume":"167","author":"X Zhu","year":"2023","unstructured":"Zhu X, Huang N, Ji Y, Sheng X, Huo J, Zhu Y, et al. Brusatol induces ferroptosis in oesophageal squamous cell carcinoma by repressing GSH synthesis and increasing the labile iron pool via inhibition of the NRF2 pathway. Biomed Pharmacother. 2023;167:115567.","journal-title":"Biomed Pharmacother"},{"key":"895_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177935","volume":"1003","author":"S Qi","year":"2025","unstructured":"Qi S, Li D, Deng F, Fu S, Chen S, Zou H, et al. Brusatol modulates the Nrf2\/GCLC pathway to enhance ferroptosis in the treatment of oral squamous cell carcinoma. Eur J Pharmacol. 2025;1003:177935.","journal-title":"Eur J Pharmacol"},{"key":"895_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156912","volume":"144","author":"L Zhang","year":"2025","unstructured":"Zhang L, Luo D, Ren H, Fan W, Yu Z, Wang S, et al. Brusatol induced ferroptosis in osteosarcoma cells by modulating the Keap1\/Nrf2\/SLC7A11 signaling pathway. Phytomedicine. 2025;144:156912.","journal-title":"Phytomedicine"},{"key":"895_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114134","volume":"158","author":"T He","year":"2023","unstructured":"He T, Zhou F, Su A, Zhang Y, Xing Z, Mi L, et al. Brusatol: a potential sensitizing agent for cancer therapy from Brucea javanica. Biomed Pharmacother. 2023;158:114134.","journal-title":"Biomed Pharmacother"},{"key":"895_CR176","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.freeradbiomed.2023.09.014","volume":"208","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Li L, Chen H, Zheng Y, Tan X, Zhang G, et al. Luteolin exhibits synergistic therapeutic efficacy with erastin to induce ferroptosis in colon cancer cells through the HIC1-mediated inhibition of GPX4 expression. Free Radic Biol Med. 2023;208:530\u201344.","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"895_CR177","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jtho.2022.09.225","volume":"18","author":"PK Paik","year":"2023","unstructured":"Paik PK, Fan PD, Qeriqi B, Namakydoust A, Daly B, Ahn L, et al. Targeting NFE2L2\/KEAP1 mutations in advanced NSCLC with the TORC1\/2 inhibitor TAK-228. J Thorac Oncol. 2023;18(4):516\u201326.","journal-title":"J Thorac Oncol"},{"issue":"5","key":"895_CR178","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2024.102123","volume":"22","author":"J Bellmunt","year":"2024","unstructured":"Bellmunt J, Maroto P, Bonfill T, Vazquez F, Perez-Gracia JL, Juanpere N, et al. Dual mTOR1\/2 inhibitor sapanisertib (FTH-003\/TAK-228) in combination with weekly paclitaxel in patients with previously treated metastatic urothelial carcinoma: a phase II open-label study. Clin Genitourin Cancer. 2024;22(5):102123.","journal-title":"Clin Genitourin Cancer"},{"key":"895_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2023.100513","volume":"43","author":"R Ge","year":"2023","unstructured":"Ge R, Huang GM. Targeting transforming growth factor beta signaling in metastatic osteosarcoma. J Bone Oncol. 2023;43:100513.","journal-title":"J Bone Oncol"},{"issue":"1","key":"895_CR180","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0570-z","volume":"11","author":"A Metelli","year":"2018","unstructured":"Metelli A, Salem M, Wallace CH, Wu BX, Li A, Li X, et al. Immunoregulatory functions and the therapeutic implications of GARP-TGF-\u03b2 in inflammation and cancer. J Hematol Oncol. 2018;11(1):24.","journal-title":"J Hematol Oncol"},{"issue":"5","key":"895_CR181","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1021\/ml200051p","volume":"2","author":"RL Dow","year":"2011","unstructured":"Dow RL, Li JC, Pence MP, Gibbs EM, LaPerle JL, Litchfield J, et al. Discovery of PF-04620110, a potent, selective, and orally bioavailable inhibitor of DGAT-1. ACS Med Chem Lett. 2011;2(5):407\u201312.","journal-title":"ACS Med Chem Lett"},{"issue":"2","key":"895_CR182","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/dom.12002","volume":"15","author":"H Denison","year":"2013","unstructured":"Denison H, Nilsson C, Kujacic M, L\u00f6fgren L, Karlsson C, Knutsson M, et al. Proof of mechanism for the DGAT1 inhibitor AZD7687: results from a first-time-in-human single-dose study. Diabetes Obes Metab. 2013;15(2):136\u201343.","journal-title":"Diabetes Obes Metab"},{"key":"895_CR183","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-015-0006-5","volume":"14","author":"CD Meyers","year":"2015","unstructured":"Meyers CD, Tremblay K, Amer A, Chen J, Jiang L, Gaudet D. Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome. Lipids Health Dis. 2015;14:8.","journal-title":"Lipids Health Dis"},{"issue":"15","key":"895_CR184","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202501046R","volume":"39","author":"MN Morshed","year":"2025","unstructured":"Morshed MN, Fitchev P, Alam MM, Majumder S, Yu X, Hayward SW, et al. DGAT1 inhibition enhances olaparib-induced lipotoxic apoptosis in metastatic castration-resistant prostate cancer. FASEB J. 2025;39(15):e70925.","journal-title":"FASEB J"},{"issue":"1","key":"895_CR185","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.clinthera.2022.12.008","volume":"45","author":"NB Amin","year":"2023","unstructured":"Amin NB, Saxena AR, Somayaji V, Dullea R. Inhibition of diacylglycerol acyltransferase 2 versus diacylglycerol acyltransferase 1: potential therapeutic implications of pharmacology. Clin Ther. 2023;45(1):55\u201370.","journal-title":"Clin Ther"},{"key":"895_CR186","doi-asserted-by":"publisher","DOI":"10.2174\/0115680096337720241030055036","author":"D Li","year":"2025","unstructured":"Li D, Guo S, Wang K, Liu Z, Yu T, Zhang Y. The COX-2 inhibitor celecoxib sensitizes nasopharyngeal carcinoma cells to ferroptosis. Curr Cancer Drug Targets. 2025. https:\/\/doi.org\/10.2174\/0115680096337720241030055036.","journal-title":"Curr Cancer Drug Targets"},{"key":"895_CR187","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.bcp.2018.05.013","volume":"154","author":"R Pritchard","year":"2018","unstructured":"Pritchard R, Rodr\u00edguez-Enr\u00edquez S, Pacheco-Vel\u00e1zquez SC, Bortnik V, Moreno-S\u00e1nchez R, Ralph S. Celecoxib inhibits mitochondrial O(2) consumption, promoting ROS dependent death of murine and human metastatic cancer cells via the apoptotic signalling pathway. Biochem Pharmacol. 2018;154:318\u201334.","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"895_CR188","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","volume":"12","author":"W Hou","year":"2016","unstructured":"Hou W, Xie Y, Song X, Sun X, Lotze MT, Zeh HJ, et al. Autophagy promotes ferroptosis by degradation of ferritin. Autophagy. 2016;12(8):1425\u20138.","journal-title":"Autophagy"},{"issue":"2","key":"895_CR189","first-page":"464","volume":"13","author":"Z Yang","year":"2023","unstructured":"Yang Z, Huang R, Wang Y, Guan Q, Li D, Wu Y, et al. SIRT6 drives sensitivity to ferroptosis in anaplastic thyroid cancer through NCOA4-dependent autophagy. Am J Cancer Res. 2023;13(2):464\u201374.","journal-title":"Am J Cancer Res"},{"issue":"8","key":"895_CR190","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/s41388-020-01622-3","volume":"40","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Kong Y, Ma Y, Ni S, Wikerholmen T, Xi K, et al. Loss of COPZ1 induces NCOA4 mediated autophagy and ferroptosis in glioblastoma cell lines. Oncogene. 2021;40(8):1425\u201339.","journal-title":"Oncogene"},{"issue":"1","key":"895_CR191","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s42003-024-06430-z","volume":"7","author":"K Subburayan","year":"2024","unstructured":"Subburayan K, Thayyullathil F, Pallichankandy S, Cheratta AR, Alakkal A, Sultana M, et al. Tumor suppressor Par-4 activates autophagy-dependent ferroptosis. Commun Biol. 2024;7(1):732.","journal-title":"Commun Biol"},{"issue":"6","key":"895_CR192","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04974-8","volume":"13","author":"K Liu","year":"2022","unstructured":"Liu K, Huang J, Liu J, Klionsky DJ, Kang R, Tang D. Induction of autophagy-dependent ferroptosis to eliminate drug-tolerant human retinoblastoma cells. Cell Death Dis. 2022;13(6):521.","journal-title":"Cell Death Dis"},{"issue":"8","key":"895_CR193","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0864-7","volume":"9","author":"M Buccarelli","year":"2018","unstructured":"Buccarelli M, Marconi M, Pacioni S, De Pascalis I, D\u2019Alessandris QG, Martini M, et al. Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis. Cell Death Dis. 2018;9(8):841.","journal-title":"Cell Death Dis"},{"issue":"15","key":"895_CR194","doi-asserted-by":"publisher","first-page":"6181","DOI":"10.7150\/ijbs.103187","volume":"20","author":"C Shan","year":"2024","unstructured":"Shan C, Wang Y, Wang Y. The crosstalk between autophagy and Nrf2 signaling in cancer: from biology to clinical applications. Int J Biol Sci. 2024;20(15):6181\u2013206.","journal-title":"Int J Biol Sci"},{"key":"895_CR195","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.2147\/OTT.S158206","volume":"11","author":"Y Xia","year":"2018","unstructured":"Xia Y, Jiang L, Zhong T. The role of HIF-1\u03b1 in chemo-\/radioresistant tumors. Onco Targets Ther. 2018;11:3003\u201311.","journal-title":"Onco Targets Ther"},{"key":"895_CR196","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2147\/JHC.S409292","volume":"10","author":"S Liu","year":"2023","unstructured":"Liu S, Kang L, Song Y, Miao M. Role of the HIF-1\u03b1\/BNIP3 signaling pathway in recurrent hepatocellular carcinoma and the mechanism of traditional Chinese medicine. J Hepatocell Carcinoma. 2023;10:893\u2013908.","journal-title":"J Hepatocell Carcinoma"},{"issue":"3","key":"895_CR197","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","volume":"15","author":"WS Yang","year":"2008","unstructured":"Yang WS, Stockwell BR. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol. 2008;15(3):234\u201345.","journal-title":"Chem Biol"},{"issue":"4","key":"895_CR198","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/j.bmcl.2011.09.047","volume":"22","author":"M Weiwer","year":"2012","unstructured":"Weiwer M, Bittker JA, Lewis TA, Shimada K, Yang WS, MacPherson L, et al. Development of small-molecule probes that selectively kill cells induced to express mutant RAS. Bioorg Med Chem Lett. 2012;22(4):1822\u20136.","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"895_CR199","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41589-020-0501-5","volume":"16","author":"JK Eaton","year":"2020","unstructured":"Eaton JK, Furst L, Ruberto RA, Moosmayer D, Hilpmann A, Ryan MJ, et al. Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles. Nat Chem Biol. 2020;16(5):497\u2013506.","journal-title":"Nat Chem Biol"},{"issue":"7","key":"895_CR200","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nchembio.2079","volume":"12","author":"K Shimada","year":"2016","unstructured":"Shimada K, Skouta R, Kaplan A, Yang WS, Hayano M, Dixon SJ, et al. Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis. Nat Chem Biol. 2016;12(7):497\u2013503.","journal-title":"Nat Chem Biol"},{"issue":"5","key":"895_CR201","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41589-018-0031-6","volume":"14","author":"MM Gaschler","year":"2018","unstructured":"Gaschler MM, Andia AA, Liu H, Csuka JM, Hurlocker B, Vaiana CA, et al. FINO2 initiates ferroptosis through GPX4 inactivation and iron oxidation. Nat Chem Biol. 2018;14(5):507\u201315.","journal-title":"Nat Chem Biol"},{"issue":"11","key":"895_CR202","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1021\/acschembio.6b00651","volume":"11","author":"A Singh","year":"2016","unstructured":"Singh A, Venkannagari S, Oh KH, Zhang Y-Q, Rohde JM, Liu L, et al. Small molecule inhibitor of NRF2 selectively intervenes therapeutic resistance in KEAP1-deficient NSCLC tumors. ACS Chem Biol. 2016;11(11):3214\u201325.","journal-title":"ACS Chem Biol"},{"issue":"11","key":"895_CR203","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.freeradbiomed.2011.03.008","volume":"50","author":"X Tang","year":"2011","unstructured":"Tang X, Wang H, Fan L, Wu X, Xin A, Ren H, et al. Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2\/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs. Free Radic Biol Med. 2011;50(11):1599\u2013609.","journal-title":"Free Radic Biol Med"},{"key":"895_CR204","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2360427","author":"Y Xiang","year":"2018","unstructured":"Xiang Y, Ye W, Huang C, Yu D, Chen H, Deng T, et al. Brusatol enhances the chemotherapy efficacy of gemcitabine in pancreatic cancer via the Nrf2 signalling pathway. Oxid Med Cell Longev. 2018. https:\/\/doi.org\/10.1155\/2018\/2360427.","journal-title":"Oxid Med Cell Longev"},{"issue":"23","key":"895_CR205","doi-asserted-by":"publisher","first-page":"10610","DOI":"10.1021\/jm301296t","volume":"55","author":"JG Barlind","year":"2012","unstructured":"Barlind JG, Bauer UA, Birch AM, Birtles S, Buckett LK, Butlin RJ, et al. Design and optimization of pyrazinecarboxamide-based inhibitors of diacylglycerol acyltransferase 1 (DGAT1) leading to a clinical candidate dimethylpyrazinecarboxamide phenylcyclohexylacetic acid (AZD7687). J Med Chem. 2012;55(23):10610\u201329.","journal-title":"J Med Chem"},{"issue":"8","key":"895_CR206","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1021\/acsmedchemlett.9b00117","volume":"10","author":"TJ Harrison","year":"2019","unstructured":"Harrison TJ, Bauer D, Berdichevsky A, Chen X, Duvadie R, Hoogheem B, et al. Successful strategies for mitigation of a preclinical signal for phototoxicity in a DGAT1 inhibitor. ACS Med Chem Lett. 2019;10(8):1128\u201333.","journal-title":"ACS Med Chem Lett"},{"issue":"22","key":"895_CR207","doi-asserted-by":"publisher","first-page":"15000","DOI":"10.1021\/acs.jmedchem.2c01200","volume":"65","author":"K Futatsugi","year":"2022","unstructured":"Futatsugi K, Cabral S, Kung DW, Huard K, Lee E, Boehm M, et al. Discovery of Ervogastat (PF-06865571): a potent and selective inhibitor of diacylglycerol acyltransferase 2 for the treatment of non-alcoholic steatohepatitis. J Med Chem. 2022;65(22):15000\u201313.","journal-title":"J Med Chem"},{"issue":"2-4","key":"895_CR208","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12029-008-9035-x","volume":"38","author":"T Fujimura","year":"2007","unstructured":"Fujimura T, Ohta T, Oyama K, Miyashita T, Miwa K. Cyclooxygenase-2 (COX-2) in carcinogenesis and selective COX-2 inhibitors for chemoprevention in gastrointestinal cancers. J Gastrointest Cancer. 2007;38(2\u20134):78\u201382.","journal-title":"J Gastrointest Cancer"},{"issue":"19","key":"895_CR209","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1016\/j.febslet.2012.07.063","volume":"586","author":"AJ Vincent","year":"2012","unstructured":"Vincent AJ, Ren S, Harris LG, Devine DJ, Samant RS, Fodstad O, et al. Cytoplasmic translocation of p21 mediates NUPR1-induced chemoresistance: NUPR1 and p21 in chemoresistance. FEBS Lett. 2012;586(19):3429\u201334.","journal-title":"FEBS Lett"},{"key":"895_CR210","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090353","author":"JC Morris","year":"2014","unstructured":"Morris JC, Tan AR, Olencki TE, Shapiro GI, Dezube BJ, Reiss M, et al. Phase I study of GC1008 (fresolimumab): a human anti-transforming growth factor-beta (TGF\u03b2) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma. PLoS ONE. 2014. https:\/\/doi.org\/10.1371\/journal.pone.0090353.","journal-title":"PLoS ONE"},{"issue":"1-2","key":"895_CR211","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cytogfr.2005.09.002","volume":"17","author":"KH Schlingensiepen","year":"2006","unstructured":"Schlingensiepen KH, Schlingensiepen R, Steinbrecher A, Hau P, Bogdahn U, Fischer-Blass B, et al. Targeted tumor therapy with the TGF-\u03b22 antisense compound AP 12009. Cytokine Growth Factor Rev. 2006;17(1\u20132):129\u201339.","journal-title":"Cytokine Growth Factor Rev"},{"key":"895_CR212","unstructured":"The innovative GARP\/TGF-\u03b21 monoclonal antibody has been approved by the FDA for clinical trials in the United States. 2023. [cited 2026 Mar 16]. https:\/\/www.jemincare.com\/news\/detail.html?id=107"},{"key":"895_CR213","unstructured":"First Subject Dosed for Phase 1 Clinical Trial of Henlius\u2019 Novel Anti-GARP\/TGF-\u03b21 mAb HLX6018. 2024. [cited 2026 Mar 16]. https:\/\/www.henlius.com\/en\/NewsDetails-4554-26.html"},{"key":"895_CR214","unstructured":"Huaaotai PD-L1\/TGF-\u03b2 dual target fusion protein project was approved by NMPA. 2022. [cited 2026 Mar 16]. https:\/\/www.huabobio.com\/newsshow\/135.html"}],"container-title":["Cellular &amp; Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-026-00895-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-026-00895-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-026-00895-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:02:16Z","timestamp":1777428136000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11658-026-00895-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":214,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["895"],"URL":"https:\/\/doi.org\/10.1186\/s11658-026-00895-y","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"68"}}